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High glucose induces MCP-1 expression partly via tyrosine Conventional peritoneal dialysis solutions used for
kinase–AP-1 pathway in peritoneal mesothelial cells. continuous ambulatory peritoneal dialysis (CAPD) pa-
Background. High glucose in peritoneal dialysis solutions tients are characterized by unphysiologically high glu-
has been implicated in the pathogenesis of peritoneal fibrosis
cose concentration as well as high osmolality and lowin chronic ambulatory peritoneal dialysis (CAPD) patients.
pH, etc. [1]. High glucose in peritoneal dialysis solutionsHowever, the mechanisms are not very clear. Peritoneal macro-
phages seem to participate in the process of peritoneal fibrosis has been implicated in the pathogenesis of peritoneal
and monocyte chemoattractant protein-1 (MCP-1) plays a key fibrosis, which is one of the serious long-term complica-
role in the recruitment of monocytes toward the peritoneal tions. High glucose may modulate the metabolism of
cavity. However, little is known about the effect of high glucose
peritoneal mesothelial cells during CAPD [2–4]. It hason MCP-1 expression and its signal transduction pathway in
been reported that high glucose suppresses the growthhuman peritoneal mesothelial cells.
and regeneration of mesothelial cells [5], induces theMethods. Mesothelial cells were cultured with glucose (5 to
100 mmol/L) or mannitol chronically for up to seven days. transforming growth factor- (TGF-) gene expression,
MCP-1 expression of mRNA and protein was measured by and increases the oxidant injury and advanced glycosyla-
Northern blot analysis and enzyme-linked immunosorbent assay tion products, all of which may contribute to the perito-
(ELISA). Chemotactic activity of high-glucose–conditioned cul-
neal fibrosis [6]. However, the mechanisms are not fullyture supernatant was measured by chemotactic assay. To exam-
understood.ine the roles of the transcription factors activator protein-1
Macrophages in the peritoneal cavity seem to partici-(AP-1) and nuclear factor-B (NF-B), electrophoretic mobil-
ity shift assay (EMSA) was performed. pate in the process of peritoneal fibrosis through the
Results. Glucose induced MCP-1 mRNA expression in a time- production of various cytokines and growth factors [7].
and dose-dependent manner. MCP-1 protein in cell culture su- Some of these factors induce the cell proliferation andpernant was also increased. Equivalent concentrations of
extracellular matrix production in mesothelial cells andmannitol had no significant effect. High-glucose–conditioned
fibroblasts, which may lead to peritoneal fibrosis [6,supernatant possessed an increased chemotactic activity for
monocytes, which was neutralized by anti–MCP-1 antibody. 8–10]. The mechanisms by which monocytes enter the
EMSA revealed that glucose increased the AP-1 binding activ- peritoneal cavity are not fully understood, but it is likely
ity in a time- and dose-dependent manner, but not NF-B. Cur- that various chemotactic factors and adhesion molecules
cumin, an inhibitor of AP-1, dose-dependently suppressed the are involved [11–13]. Monocyte chemoattractant protein-1induction of MCP-1 mRNA by high glucose. Tyrosine kinase
(MCP-1), a potent chemokine with considerable speci-inhibitors such as genistein (12.5 to 50 mol/L) and herbimycin
ficity for monocytes, has been reported to play a key roleA (0.1 to 1 mol/L) inhibited the high-glucose–induced MCP-1
mRNA expression in a dose-dependent manner, and also sup- in the recruitment of monocytes toward the peritoneal
pressed the high-glucose–induced AP-1 binding activity. cavity [14]. In addition to chemotactic activity, MCP-1
Conclusions. High glucose induced mesothelial MCP-1 ex- can induce calcium flux and respiratory burst activity
pression partly via the tyrosine kinase-AP-1 pathway.
and also regulate the adhesion molecule expressions and
cytokine productions in monocytes [15, 16]. It is also
known that MCP-1 can stimulate the TGF- productionKey words: CAPD, dialysate, fibrosis, monocyte chemoattractant pro-
tein-1, activator protein-1, signal transduction. in lung fibroblast [17].
However, the effects of high glucose on MCP-1 expres-Received for publication August 22, 2000
sion in human peritoneal mesothelial cells (HPMCs) areand in revised form January 12, 2001
Accepted for publication January 29, 2001 not yet known.
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transcriptional regulation of MCP-1. In the human MCP-1 appearance and by the presence of vimentin and cytoker-
atin and the absence of factor VIII antigen using immu-gene, tissue-type plasminogen activator (t-PA)–respon-
sive elements (TRE) and B enhancer element exist at nofluorescence methods. Mesothelial cells under passage
3 were used for the experiments.the 5-flanking region of MCP-1 gene, suggesting the role
of activator protein-1 (AP-1) and nuclear factor-B
Cell culture conditioning(NF-B) [18]. In addition, several cellular kinases are
involved in the activation of MCP-1 gene, including pro- To evaluate the effect of chronic exposure of high glu-
cose concentration on the MCP-1 expression, HPMCstein kinase C (PKC) and protein tyrosine kinase (PTK)
[19]. Although it has been widely assumed that high were conditioned in 100 mm culture dish with glucose
(5 to 100 mmol/L) for varying periods up to seven daysglucose increases the expression of NF-B via the PKC-
dependent pathway [20], little has been known about in the presence of serum-containing media [22]. Culture
media were changed every three days. To examine the ef-the high-glucose–mediated signal transduction pathways
involved in mesothelial MCP-1 gene expression. fect of osmolality on MCP-1 expression, HPMCs were con-
ditioned with mannitol (50 to 100 mmol/L) for six days.The purpose of this study was to evaluate the effect
of high glucose on MCP-1 expression in HPMCs and to Monocyte chemoattractant protein-1 mRNA expres-
sion, MCP-1 protein expression, and chemotactic activi-determine the high-glucose–mediated signal transduc-
tion pathways involved in MCP-1 gene expression. ties were measured at the time points indicated.
To examine the role of transcription factor AP-1 and
NF-B in high-glucose–induced MCP-1 gene expression,
METHODS
electrophoretic mobility shift assay (EMSA) was per-
Reagent formed at the time points indicated. The effect of AP-1
inhibitor curcumin (7.5 to 15 mol/L) on the high-glu-M199 medium and other cell culture reagents were
obtained from GIBCO BRL (Grand Island, NY, USA). cose–induced MCP-1 mRNA expression and on AP-1
or NF-B binding activity was examined.The human MCP-1 enzyme-linked immunosorbent assay
(ELISA) kit (Quantikine) and anti-human MCP-1 anti- To determine the involvement of tyrosine kinase path-
way in glucose-induced MCP-1 expression, HPMCs werebody were obtained from R&D Systems Inc. (Minneapo-
lis, MN, USA). The Tri Reagent Kit was obtained from preincubated for one hour with PTK inhibitors such as
genistein (12.5 to 50 mol/L) and herbimycin A (0.1 to 1Molecular Research Center, Inc. (Cincinnati, OH, USA).
Moloney murine leukemia virus H-reverse transcriptase mol/L), and then Northern blot analysis and EMSA
were performed. Cell viability measured by trypan blue(Superscript) was obtained from BRL (Gaithersburg, MD,
USA), and other reagents used for reverse transcription exclusion was not adversely effected by these inhibitors
in this experiment.were obtained from Boehringer Mannheim (Mannheim,
Germany). Genistein and herbimycin A were obtained
RNA isolation and Northern hybridizationfrom Sigma Chemical Company (St. Louis, MO, USA).
Double-stranded AP-1 and NF-B oligonucleotides Total cellular RNA was extracted using a commer-
cially available modification of the acid-phenol methodwere obtained from Promega (Madison, WI, USA).
(Tri Reagent Kit). The amount of RNA was quantitated
Cell culture by absorbance at 260 nm, and purity of RNA was as-
sessed by absorbance ratio at 260/280 nm. Northern hy-Human peritoneal mesothelial cells (HPMC) were ob-
tained from omental tissue of consenting patients under- bridization was performed as previously described [23].
Briefly, RNA (10 g/lane) was electrophoresed throughgoing elective abdominal surgery. Cells were isolated
by modification of a method described previously [21]. 1% agarose, 2.2 mol/L formaldehyde denaturing gel
with MOPS buffer, followed by capillary transfer to ny-Briefly, omental tissue was rinsed in phosphate-buffered
saline (PBS), transferred to a solution of 0.125% trypsin lon membranes. Filters were stained with methylene blue
to check the integrity, uniformity of loading, and transferand 0.01% ethylenediaminetetraacetic acid (EDTA),
and allowed to float for 20 minutes at 37C. Thereafter, of RNA prior to fixation in vacuo at 80C for two hours.
Filters were prehybridized at 65C in 0.5 mol/L NaHPO4fat tissue was removed, and detached mesothelial cells
were collected by centrifugation (5 min at 50  g). buffer, pH 7.0, 1 mmol/L EDTA, 7% sodium dodecyl
sulfate (SDS), and 1% bovine serum albumin for four toHPMCs were cultured in M199 medium supplemented
with 10% fetal calf serum, penicillin (100 U/mL), strepto- six hours. Then, filters were hybridized with 32P-labeled
cDNA probes and 100 g/mL salmon sperm DNA atmycin (10 g/mL), and fungizone (0.25 ng/mL) at 37C
in a humidified atmosphere of 5% CO2. The media were 65C overnight. cDNA probes were labeled with 32P using
random primers (Megaprime DNA labeling system;changed every three days, and cells were subcultured
by 0.05% trypsin and 0.02% EDTA when they became Amersham International, Buckinghamshire, UK). Fil-
ters were washed and exposed to film at70C. Intensit-confluent. HPMCs were identified by typical cobblestone
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ies of the bands on autoradiogram were quantitated by hours and careful washes, polyclonal antibody conju-
gated to horseradish peroxidase against MCP-1 wasthe scanning laser densitometry (GS-670 imaging densi-
tomter; Bio-Rad, Hercules, CA, USA). The same filters added. After another incubation for one hour at room
temperature and repeated washes, color reagents werewere rehybridized with a cDNA specific for glyceralde-
hyde-3-phosphate-dehydrogenase (GAPDH) to correct added. Optical density of each well was measured at
450 nm with an ELISA reader, using a 570 nm referencefor variation in RNA loading and transfer efficiency.
wavelength.
Generation of cDNA probes
Chemotaxis assaycDNA probes specific for human MCP-1 and GAPDH
were made by the reverse transcription-polymerase The chemotactic activity of conditioned cell culture
supernatant was assessed using 48-well microchemotaxischain reaction (RT-PCR) method. RT-PCR was per-
formed as previously described [23]. Briefly, oligo (dT) chambers (Neuroprobe, Cabin Jhon, MD, USA) as pre-
viously described [26]. Briefly, human peripheral blood(0.5 g; Boehringer-Mannheim, Mannheim, Germany)
was annealed to total RNA (20 g, from interleu- mononuclear cells were isolated by centrifugation through
Ficoll-Hypaque. Monocytes were purified from thesekin-1–stimulated human mesothelial cells) after dena-
turation at 70C, and cDNA was synthesized at 42C for preparations by the method of Rich et al [27]. Cell viabil-
ity was evaluated by trypan blue exclusion and shouldone hour using 100 U of Superscript (BRL, Gaithers-
burg, MD, USA) in a final volume of 20 L of the be95%. Purified monocytes suspensions (5 104 cells/
well) were added to the top well of the chamber andvendor’s buffer supplemented with 20 U RNAsin (Pro-
mega Biotec, Madison, WI, USA). cDNA was precipi- permitted to migrate through a 10 m thick, 5 m poros-
ity polycarbonate membrane (Nucleopore Corp., Pleas-tated and dissolved in 1 mmol/L EDTA, 10 mmol/L Tris,
pH 7.4. After RT, PCR was performed in PCR buffer anton, CA, USA) toward the sample-bearing bottom
chamber, which contained conditioned cell culture su-containing 0.25 mmol/L dNTP, 12.5 pmol of each primer
and 1.25 U of Taq polymerase (Perkin-Elmer Cetus, pernatant. Monocytes were incubated for 90 minutes at
37C in humidified air with 5% CO2. After incubation,Norwalk, CT, USA) in a total volume of 50 L with
initial denaturation at 94C for 3.5 minutes, followed by the membrane was removed. Nonmigrating cells were
wiped off, and the polycarbonate membrane was fixed30 cycles of 94C for 1.5 minutes, 54C for 1.5 minutes,
and 72C for 1.5 minutes. After 30 cycles, a final exten- for five minutes in absolute methanol, followed by air
drying and staining for 30 minutes in Wright’s Giemsa.sion at 72C for eight minutes was performed. Each PCR
primer set was synthesized (Korea Biotech, Inc., Seoul, The number of cells migrating through the membrane
was counted in three random 10 mm grids at 400 forKorea) according to the published cDNA sequences for
human MCP-1 and GAPDH [24, 25]. triplicated samples. Chemotactic activity was standard-
ized to and expressed as the percentage of the positiveThe sequences of each primer set were as follows:
MCP-1, forward primer 5-AAGCTCGCACTCTCGC control (108 mol/L, f-Met-Leu-Phe) as previously re-
ported [26, 28, 29].CTC-3 and backward primer 5-CAGGGTGTCTGGG
GAAAGC-3; GAPDH, forward primer 5-TCACCAT To examine whether glucose-induced chemotactic ac-
tivity for monocytes was mediated through MCP-1, aCTTCCAGGAGCG-3 and backward primer 5-CTGC
TTCACCACCTTCTTGA-3. neutralizing test was performed using specific anti–
MCP-1 antibody (20 g/mL) and an equivalent concen-Polymerase chain reaction products were electro-
phoresed on an ethidium bromide-stained 1% agarose tration of nonspecific antibody.
gel, and the expected size of each PCR product was
Extraction of nuclear protein and EMSAconfirmed under ultraviolet illumination. PCR products
were purified using a Jetsorb gel extraction kit (Geno- Nuclear extracts were prepared by modification of a
method described previously [30]. Briefly, cells were gen-med, Inc., Research Triangle Park, NC, USA).
tly washed twice with ice-cold PBS and scraped in 1 mL
Enzyme-linked immunosorbent assay for of ice-cold hypotonic lysis buffer [10 mmol/L HEPES-
MCP-1 protein KOH, pH 7.9, 60 mmol/L KCl, 1 mmol/L EDTA, 1 mmol/L
dithiothreitol (DTT), 1 mmol/L phenylmethylsulfonylMonocyte chemoattractant protein-1 protein in cell
culture supernatant was measured by enzyme-linked im- fluoride (PMSF), and 0.5% Nonidet P-40]. The cells were
vortexed and allowed to swell on ice for 10 minutes. Themunosorbent assay (ELISA). The ELISA method was a
specific sandwich enzyme immunoassay (Human MCP-1 nuclei were collected by centrifugation at 2000 r.p.m. for
five minutes at 4C. The nuclear pellet were resuspendedkit, Quantikine; R&D). Briefly, diluted cell culture su-
pernatant was added to 96-well microtiter plate that was in 100 L of high salt extraction buffer (20 mmol/L
HEPES-KOH, pH 7.9, 0.42 mol/L NaCl, 1.2 mmol/Lcoated with murine monoclonal antibody against human
MCP-1. After incubation at room temperature for two MgCl2, 0.5 mmol/L DTT, 0.2 mmol/L EDTA, 25% glyc-
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Fig. 1. Induction of monocyte chemoattractant protein-1 (MCP-1)
mRNA by glucose. (A) Time-dependent induction of MCP-1 mRNA
by glucose. Human peritoneal mesangial cells (HPMCs) were exposed
to 5 mmol/L glucose [control (C)] and 100 mmol/L glucose (G) for up
to seven days. Northern blot analysis was performed. Results shown
are representative of three experiments. (B) Dose-dependent induction
of MCP-1 mRNA by glucose: HPMCs were exposed to varying concen-
tration of glucose for five days.
erol, 0.5 mmol/L PMSF, 5 g/mL aprotinin, 5 g/mL
Fig. 2. Quantitation of MCP-1 mRNA expression in mesothelial cellsleupeptin) and incubated for 20 minutes on ice with
cultured for six days with glucose or mannitol. HPMCs were exposed to
shaking. The nuclear extract was then centrifuged for 15 5 mmol/L glucose (control), 50 mmol/L, 100 mmol/L glucose, 50 mmol/L
mannitol, or 100 mmol/L mannitol for six days. Northern blot analysisminutes at 4C, and the supernatant was stored at80C.
was performed (A), and the MCP-1 mRNA level was normalized by
Protein concentration was determined using a colorimet- the GAPDH mRNA level (B). Data were mean 	 SE of three experi-
ments. aP 
 0.05 vs. control.ric assay based on the method of Bradford [31].
Electrophoretic mobility shift assay was performed by
incubation of nuclear protein (10 g) with 32P-labeled
AP-1 or NF-B oligonucleotides at room temperature for RESULTS
20 minutes in binding buffer containing 50 mmol/L Tris,
Effect of high glucose and mannitol on MCP-1pH 7.5, 250 mmol/L NaCl, 20% glycerol, 5 mmol/L MgCl2, mRNA expression2.5 mmol/L EDTA, 2.5 mmol/L DTT, 0.25 mg/mL poly
Incubation of HPMCs with high glucose (100 mmol/L)(dI-dC). Double-stranded AP-1 oligonucleotides (5-CGC
increased the MCP-1 mRNA expression in a time-TTGATGAGTCAGCCGGAA-3) and NF-B oligonu-
dependent (2 to 7 days) and dose-dependent mannercleotides (5-AGTTGAGGGGACTTTCCCAGGC-3)
(12.5 to 100 mmol/L glucose; Fig. 1). HPMCs culturedwere labeled with -32P-ATP using T4 kinase and purified
in 50 mmol/L and 100 mmol/L glucose for six days dem-on a Sephadex G-25 column. Nucleoprotein-oligonucle-
onstrated an increase in MCP-1 mRNA expression ap-otide complexes were resolved by electrophoresis on
proximately 2.6 	 0.3-fold and 3.3 	 0.4-fold, respec-
4% nondenaturing polyacrylamide gels in 0.25  TBE
tively, when compared with cells cultured in 5 mmol/L
buffer. The gel was dried and autoradiographed with
glucose (Fig. 2). To examine the effect of osmolality on
intensifying screen at70C. Competition assay was per- MCP-1 mRNA expression, HPMCs were cultured in 50
formed by 10 minutes of preincubation of nuclear protein and 100 mmol/L mannitol for six days. As shown in
with 100 times excess unlabeled AP-1 or NF-B oligonu- Figure 2, incubation of HPMCs with 50 and 100 mmol/L
cleotides and nonspecific oligonucleotides mannitol had no significant effect on MCP-1 mRNA
expression.
Statistics
Effect of high glucose and mannitol on MCP-1All data were expressed as mean 	 SE. Groups were
protein expressioncompared using an analysis of variance test for multiple
group comparison (Scheffe’s method). A P value less Monocyte chemoattractant protein-1 protein levels in
cell culture supernatant were determined from HPMCsthan 0.05 was considered significant.
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In addition, basal chemotactic activity from HPMCs
cultured in 5 mmol/L glucose was also inhibited by anti–
MCP-1 antibody (Fig. 4).
Involvement of transcription factor AP-1 in
glucose-induced MCP-1 gene expression
It has been reported that activation of AP-1 or NF-B
is essential for the induction of MCP-1. To examine
whether high-glucose–induced MCP-1 gene expression
was mediated by the activation of AP-1 or NF-B, nu-
clear protein extracts from mesothelial cells stimulated
by high glucose were subjected to EMSA. Because
Northern blot analysis revealed that high glucose in-
Fig. 3. Effect of glucose and mannitol on the cell supernatant MCP-1 creased MCP-1 mRNA expression in a time-dependentprotein. HPMCs were exposed to 5 mmol/L glucose (control), 50 mmol/L
(2 to 7 days) manner, EMSAs were performed with nu-glucose, 100 mmol/L glucose, and 100 mmol/L mannitol for six days.
MCP-1 protein in cell culture supernatant was measured by ELISA. clear proteins obtained from mesothelial cells cultured
aP 
 0.05 vs. control. for one, three, and five days in 5 and 100 mmol/L glucose,
respectively. EMSA revealed that high glucose increased
the AP-1 binding activity in a time-dependent (1 to 5
days) and dose-dependent manner (12.5 to 100 mmol/Lcultured in 5, 50, 100 mmol/L glucose and 100 mmol/L
glucose; Fig. 5). However, there were no significantmannitol for six days. As shown in Figure 3, incubation
changes in the activity of NF-B binding (Fig. 6A). Aof HPMCs with 50 and 100 mmol/L glucose for six days
competition assay was performed to demonstrate speci-increased the MCP-1 protein level approximately 1.9 	
ficity of AP-1 and NF-B binding activity observed in0.2- and 2.8	 0.4-fold, respectively, when compared with
the EMSA. Preincubation with excess unlabeled double-cells cultured in 5 mmol/L glucose; 100 mmol/L mannitol
stranded AP-1 or NF-B oligonucleotides in the DNAhad no significant effect. Each data point in Figure 3
binding reaction effectively blocked the formation ofrepresented the MCP-1 protein level for the previous 72
specific DNA/protein complex. Nonspecific oligonucleo-hours because all cell culture media were changed every
tides did not affect the AP-1 and NF-B binding activity72 hours.
observed in the EMSA (Figs. 5C and 6B).
The effects of a pharmacological inhibitor of AP-1,Effect of high glucose on the chemotactic activity
curcumin, on the high-glucose–induced MCP-1 mRNAfor monocytes
expression and high-glucose–induced AP-1 binding ac-
Chemotactic activity was standardized to and expressed
tivity was examined further. Curcumin dose-dependently
as the percentage of the positive control (108 mol/L, suppressed the high-glucose–induced MCP-1 mRNA ex-
f-Met-Leu-Phe) as previously reported [26, 28, 29]. pression (Fig. 7) and the high-glucose–induced AP-1 ac-
Supernatants obtained from HPMCs cultured in 100 tivity (Fig. 8B). However, curcumin inhibited the basal
mmol/L glucose for six days showed higher levels of NF-B binding activity both in control cells and in cells
chemotactic activity for monocytes than those from stimulated with glucose (Fig. 9).
HPMCs cultured in 5 mmol/L glucose and media con-
taining 100 mmol/L glucose only (Fig. 4). Involvement of PTK in high glucose-induced MCP-1
To examine whether high-glucose–induced chemotac- gene expression
tic activity was mediated through MCP-1, we attempted Several cellular kinases are involved in the activation
to neutralize the chemotactic activity of the conditioned of MCP-1 gene, including PTK. To determine whether
supernatant with a specific anti–MCP-1 antibody. The ad- the activation of tyrosine kinase was an essential event
dition of a specific anti–MCP-1 antibody (20 g/mL) for the MCP-1 induction by glucose, we examined the
significantly inhibited the chemotactic activity induced effect of PTK inhibitor such as genistein and herbimy-
by high glucose. Equivalent concentration of nonspe- cin A on the high glucose-induced MCP-1 mRNA ex-
cific antibody did not affect the chemotactic activity in- pression. Northern blot analysis revealed that genistein
duced by high glucose. Furthermore, f-Met-Leu-Phe (12.5 to 50 mol/L) and herbimycin (0.1 to 1 mol/L)
(108 mol/L)-induced chemotactic activity was not al- suppressed the high-glucose–induced MCP-1 mRNA ex-
tered by anti–MCP-1 antibody (Fig. 4). These findings pression in a dose-dependent manner (Fig. 8A).
suggested that high-glucose–induced MCP-1 production To investigate whether the activation of tyrosine ki-
contributed to a significant proportion of the overall nase was located upstream of AP-1, we examined the ef-
fect of tyrosine kinase inhibitors on high-glucose–inducedhigh-glucose–induced monocyte chemotactic activity.
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Fig. 4. Effect of high glucose on the chemo-
tactic activity for monocytes and inhibition by
anti–MCP-1 antibody. HPMCs were exposed
to 5 mmol/L glucose (control) and 100 mmol/L
glucose for six days. Chemotactic activity in
cell-free supernatants before and after the ad-
dition of anti–MCP-1 antibody (20 g/mL) or
nonspecific antibody (20g/mL) was measured
by chemotactic assay. Data are expressed as
a percentage of maximum monocyte chemo-
tactic response to f-Met-Leu-Phe (FMLP) 108
mol/L. Results were expressed as mean 	 SE
of six experiments. aP 
 0.05 vs. control; bP 

0.05 vs. before the addition of anti–MCP-1
antibody.
Fig. 5. Effect of high glucose on activator
protein-1 (AP-1) binding activity. (A) Time-
dependent increase in AP-1 binding activity
by high glucose. Electrophoretic mobility shift
assays (EMSA) were performed with nuclear
proteins from HPMCs cultured for up to five
days in 5 mmol/L glucose (C) and 100 mmol/L
glucose (G). Results shown are representative
of three experiments. (B) Dose-dependent in-
crease in AP-1 binding activity by glucose.
EMSAs were performed from mesothelial cells
cultured with varying doses of glucose for
three days. (C ) Competition assay of AP-1
binding activity. Competition assay was per-
formed to demonstrate the specificity of AP-1
binding activity. Nuclear protein from HPMCs
cultured for three days in 100 mmol/L glucose
(Control) was preincubated with 100 times ex-
cess unlabeled AP-1 oligonucleotide (Competi-
tion) and nonspecific oligonucleotide (NS com-
petition) for 10 minutes, and then EMSA was
performed.
AP-1 binding activity. EMSA revealed that genistein and seven days. Then, the effect of high glucose on the MCP-1
expression in mesothelial cells was evaluated. Next, weherbimycin suppressed the high-glucose–induced AP-1
investigated the high-glucose–mediated signal transduc-binding activity at the concentration that inhibited the
tion pathways involved in MCP-1 gene expression.high-glucose–induced MCP-1 mRNA expression (Fig. 8B).
Mesothelial cells are the most abundant cells in theWe further examined the effect of tyrosine kinase in-
peritoneum and play an important role in the controlhibitors on NF-B binding activity, and found that they
of inflammation in the peritoneal cavity. Induction ofhad no significant effect (Fig. 9A).
MCP-1 in mesothelial cells by various cytokines andThese findings suggested that tyrosine kinase was re-
growth factors, including interleukin-1, tumor necrosisquired for the activation of AP-1, which was essential
factor-, and interferon-, has been demonstrated [32].to the induction of MCP-1 gene expression by glucose.
MCP-1 has been reported to play a key role in the recruit-
ment of monocytes toward the peritoneal cavity [14]. In
DISCUSSION addition to its role in cellular immune reactions and
This study simulated the high-glucose conditions in responses to acute tissue injury, MCP-1 has been sug-
CAPD by using mesothelial cells cultured under high- gested as an important mediator in human diseases. This
is supported by evidence that MCP-1 is expressed inglucose concentrations of up to 100 mmol/L for up to
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Fig. 6. Effect of high glucose on nuclear factor-B (NF-B) binding
activity. (A) EMSAs were performed with nuclear proteins from HPMCs Fig. 7. Effect of AP-1 inhibitor, curcumin, on induction of MCP-1cultured for up to five days in 5 mmol/L glucose (C) and 100 mmol/L mRNA by high glucose. HPMCs grown in normal (5 mmol/L) and highglucose (G). Results shown are representative of three experiments. glucose (100 mmol/L) for three days were treated with curcumin for(B) Competition assay was performed to demonstrate the specificity of 24 hours, and then Northern blot analysis was performed.NF-B binding activity. Nuclear protein from HPMCs cultured for three
days in 100 mmol/L glucose (Control) was preincubated with 100 times
excess unlabeled NF-B oligonucleotide (Competition) and nonspecific
oligonucleotide (NS competition) for 10 minutes, and then EMSA was
performed. in 5 mmol/L glucose in our study appeared higher than
expected. We thought that one of the possible reasons
was that, in our study, cells were conditioned with glu-
cose in the presence of serum-containing media.atherosclerotic lesion [33] and glomerulonephritis [34].
Monocyte chemoattractant protein-1 gene can be acti-Similarly, MCP-1 is expressed in human melanoma but
vated by PKC- or PTK-dependent pathway and down-not in normal skin [35].
stream transcription factors such as AP-1 or NF-B [19].However, little has been known about the effect of
It has been widely assumed that high glucose increaseshigh glucose on MCP-1 expression in HPMCs.
the expression of NF-B and that this process is mediatedWe found that glucose increased MCP-1 mRNA ex-
via PKC-dependent pathway [20], which suggests a possi-pression in a time- (2 to 7 days) and dose-dependent
ble role of the PKC–NF-B pathway in high-glucose–manner. MCP-1 protein in cell culture supernatant was
induced MCP-1 gene expression. However, another im-also increased. An equivalent concentration of mannitol
portant aspect of MCP-1 signal transduction is thehad no significant effect on the MCP-1 mRNA and pro-
transcription activation promoted by the binding of AP-1tein expression, suggesting that glucose-induced up-regu-
to TRE. Previous reports have shown that activation oflation of MCP-1 was independent of osmolality. Further-
AP-1 is required for the induction of MCP-1 by lipopoly-more, high-glucose–conditioned supernatant possessed
saccharide, mechanical stress, TGF- in macrophages,the increased chemotactic activity for monocytes, which
vascular endothelial cells, and osteoblastic cells, respec-was neutralized by specific anti–MCP-1 antibody. The
tively [38–40]. Furthermore, increased binding of AP-1addition of anti–MCP-1 antibody almost completely in-
to TRE in high-glucose environments was also reportedhibited the increased portion of chemotactic activity by
in human mesangial cells cultured chronically for fivehigh glucose, suggesting that increased portion of chemo-
days [22] and in porcine vascular smooth muscle cellstactic activity by high glucose was mainly due to MCP-1
cultured chronically for three to nine days [41], sug-production by high glucose. These findings may suggest
gesting a possible role of AP-1 in high-glucose–induceda possibility that high glucose in peritoneal dialysis solu-
MCP-1 gene expression.tions may contribute to the peritoneal fibrosis by up-
To examine whether high-glucose–induced MCP-1regulating the mesothelial synthesis of MCP-1. In addi-
gene expression was mediated by the activation of AP-1tion, long-term exposure of high glucose in the peritoneal
or NF-B, we measured the activity of AP-1 and NF-Bdialysate of CAPD patients has been shown to facilitate
in mesothelial cells cultured with high glucose for one,advanced glycation end product (AGE) formation in
three, and five days because high glucose increasedthe peritoneal membrane [36], and an accumulation of
MCP-1 mRNA expression progressively during the studyAGEs induces the progression of peritoneal fibrosis and
periods (2 to 7 days).microvascular sclerosis [37].
Basal chemotactic activity from control cells cultured We found that high glucose increased the AP-1 bind-
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Fig. 8. Effect of tyrosine kinase inhibitors on
high-glucose–induced MCP-1 mRNA expres-
sion and high-glucose–induced AP-1 binding
activity. (A) HPMCs were exposed to 100
mmol/L glucose for three days with or without
varying dose of genistein and herbimycin A.
Northern blot analysis was performed. Results
shown are representative of two experiments.
(B) Suppression of high-glucose–induced AP-1
binding activity by genistein, herbimycin A
and curcumin. EMSAs were performed with
nuclear proteins from mesothelial cells cul-
tured for three days in 100 mmol/L glucose
with or without 50 mol/L genistein (Ge), 1
mol/L herbimycin A (He), and 15 mol/L
curcumin (Cu). Results shown are representa-
tive of three experiments.
Fig. 9. Effect of tyrosine kinase inhibitors
and curcumin on the NF-B binding activity.
(A) Effect of genistein (Ge), herbimycin A
(He), and curcumin (Cu) on the NF-B bind-
ing activity in mesothelial cells incubated with
100 mmol/L glucose. EMSAs were performed
with nuclear proteins from mesothelial cells
cultured for three days in 100 mmol/L glucose
with or without 50 mol/L genistein (Ge), 1
mol/L herbimycin A (He), and 15 mol/L
curcumin (Cu). Results shown are representa-
tive of three experiments. (B) EMSAs were
performed with nuclear proteins from meso-
thelial cells cultured for three days in 5
mmol/L glucose (control) with or without 15
mol/L curcumin (Cu).
ing activity in a time- and dose-dependent manner. Fur- is a relatively early event. In endothelial cells, high-glu-
cose–induced NF-B activity was observed as early as onethermore, a pharmacological inhibitor of AP-1, curcumin,
dose-dependently suppressed the high-glucose–induced hour after stimulation (peak activation at 2 to 4 hours)
and then decreased thereafter [43].MCP-1 mRNA expression and the high glucose-induced
AP-1 activity. These findings suggest that activation of Several cellular kinases are involved in the activation
of the MCP-1 gene, including PKC and PTK [19]. Previ-AP-1 is essential to induction of MCP-1 gene expression
in mesothelial cells cultured chronically with high glucose. ous studies have shown that activation of PTK is required
for the induction of MCP-1 gene expression by PDGF,However, curcumin has been reported to inhibit NF-B
activity as well [42]. Therefore, we examined the effect IL-1 and TNF- in renal mesangial cells [44–46]. To
determine whether the activation of PTK was an essen-of curcumin on the NF-B binding activity. In our study,
curcumin suppressed the basal NF-B binding activity tial event for the glucose-induced MCP-1 gene expres-
sion, we examined the effect of PTK inhibitors suchboth in control cells and in cells stimulated with glucose.
It has been widely assumed that high glucose increases as genistein and herbimycin A on high-glucose–induced
MCP-1 gene expression. We found that both genisteinthe expression of NF-B [20]. However, we found no
significant changes in NF-B binding activity in mesothe- and herbimycin A suppressed the high-glucose–induced
MCP-1 mRNA expression in a dose-dependent manner.lial cells cultured with high glucose for one, three, and
five days. This discrepancy may be explained by the fact Furthermore, genistein and herbimycin A suppressed
the high-glucose–induced increased AP-1 binding activ-that the increase in high-glucose–induced NF-B activity
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